Danaher Corp DHR:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

Last | 3:57 PM EDT

246.32

-0.57 (-0.23%)

Volume

1,566,077

52 week range

182.09 - 259.00

Open248.99
Day High249.43
Day Low242.66
Prev Close246.89
52 Week High259.00
52 Week High Date03/04/24
52 Week Low182.09
52 Week Low Date10/30/23

Key Stats

Market Cap182.446B
Shares Out740.69M
10 Day Average Volume3.32M
Dividend1.08
Dividend Yield0.44%
Beta0.86
YTD % Change6.17

KEY STATS

Open248.99
Day High249.43
Day Low242.66
Prev Close246.89
52 Week High259.00
52 Week High Date03/04/24
52 Week Low182.09
52 Week Low Date10/30/23
Market Cap182.446B
Shares Out740.69M
10 Day Average Volume3.32M
Dividend1.08
Dividend Yield0.44%
Beta0.86
YTD % Change6.17

RATIOS/PROFITABILITY

EPS (TTM)5.95
P/E (TTM)41.37
Fwd P/E (NTM)33.40
EBITDA (TTM)7.441B
ROE (TTM)7.88%
Revenue (TTM)23.737B
Gross Margin (TTM)58.39%
Net Margin (TTM)17.14%
Debt To Equity (MRQ)33.99%

EVENTS

Earnings Date07/23/2024(est)
Ex Div Date03/27/2024
Div Amount0.27
Split Date-
Split Factor-

Latest On Danaher Corp

12 portfolio companies report in the week ahead. What we want to hear from eachApril 27, 2024CNBC.com
A rapid-fire update on our 33 stocks including the tech giants reporting this weekApril 24, 2024CNBC.com
April Monthly Meeting: Jim Cramer shares his outlook as earnings season heats upApril 24, 2024CNBC.com
Jim Cramer's top 10 things to watch in the stock market WednesdayApril 24, 2024CNBC.com
Here are the portfolio's top 5 performing stocks since the March Monthly MeetingApril 24, 2024CNBC.com

Content From Our Affiliates

Danaher call volume above normal and directionally bullishMay 1, 2024TipRanks
Fly Insider: Zura Bio, Google among week’s notable insider tradesApril 29, 2024TipRanks
ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside?April 26, 2024TipRanks
Buy Rating on Danaher: Strong Biotech Performance and Growth Potential Despite Market ChallengesApril 26, 2024TipRanks
Danaher price target raised to $270 from $258 at BofAApril 24, 2024TipRanks

Profile

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life...

Steven Rales

Chairman of the Board

Rainer Blair

President, Chief Executive Officer, Director

Matthew McGrew

Chief Financial Officer, Executive Vice President

Joakim Weidemanis

Executive Vice President

Christopher Riley

Executive Vice President

Address

2200 Pennsylvania Ave NW Ste 800W

Washington, DC

20037-1731

United States

https://www.danaher.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
ABT Abbott Laboratories	105.78	-0.52	-0.48%
SYK Stryker Corp	325.80	-2.32	-0.71%
MDT Medtronic PLC	80.84	-0.05	-0.06%
TMO Thermo Fisher Scientific Inc	570.92	-4.07	-0.71%
BSX Boston Scientific Corp	71.92	-0.29	-0.40%